Clinical Trial Update: Expanded Access Metreleptin Study

View source ↗

Summary

Expanded access study of metreleptin for Familial Partial Lipodystrophy sponsored by the University of Michigan. The study status is AVAILABLE.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Partial Lipodystrophy

Drugs mentioned

• MYALEPT (METRELEPTIN)

Snippet

Sponsor: University of Michigan | Conditions: Familial Partial Lipodystrophy | Status: AVAILABLE